Immunological effects of behavioral activation with exercise in major depression: An exploratory randomized controlled trial

Translational Psychiatry

Volumn 7, Issue 5, 2017, Pages

  Euteneuer, F ^a   Dannehl, K ^a   Del Rey, A ^a   Engler, H ^b   Schedlowski, M ^b   Rief, W ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; BEHAVIOR; BEHAVIORAL ACTIVATION; CARDIOVASCULAR RISK; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXERCISE; EXERCISE INTENSITY; FEMALE; HOSPITAL ADMISSION; HUMAN; IMMUNITY; IMMUNOCOMPETENT CELL; LEUKOCYTE COUNT; LOW ENERGY ACTIVITY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOCYTE COUNT; NEUTROPHIL COUNT; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; WALKING; BLOOD; CARDIOVASCULAR DISEASE; CELL COUNT; COGNITIVE THERAPY; COMPLICATION; CYTOLOGY; EPIDEMIOLOGY; GERMANY; IMMUNOLOGY; INFLAMMATION; KINESIOTHERAPY; METABOLISM; MIDDLE AGED; MONOCYTE; NEUTROPHIL; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; RISK FACTOR;

ADULT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CELL COUNT; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; EXERCISE; EXERCISE THERAPY; FEMALE; GERMANY; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; RISK FACTORS;

EID: 85019626059     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2017.76     Document Type: Article

References (98)

1. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A metaanalysisof cytokines in major depression. Biol Psychiatry 2010; 67: 446-457.
2. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, IL-6: A meta-analysis. Psychosom Med 2009; 71: 171-186.
3. Stewart JC, Rand KL, Muldoon MF, Kamarck TW. A prospective evaluation of thedirectionality of the depression-inflammation relationship. Brain Behav Immun2009; 23: 936-944.
4. Miller AH, Raison CL. The role of inflammation in depression: From evolutionaryimperative to modern treatment target. Nat Rev Immunol 2015; 16: 22-34.
5. Kiecolt-Glaser JK, Derry HM, Fagundes CP. Inflammation: Depression fans theflames and feasts on the heat. Am J Psychiatry 2015; 172: 1075-1091.
6. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammationto sickness and depression: When the immune system subjugates the brain. NatRev Neurosci 2008; 9: 46-56.
7. Dhabhar FS, Burke HM, Epel ES, Mellon SH, Rosser R, Reus VI, et al. Low serum IL-10concentrations and loss of regulatory association between IL-6 and IL-10 in adultswith major depression. J Psychiatr Res 2009; 43: 962-969.
8. Song C, Halbreich U, Han C, Leonard BE, Luo H. Imbalance between pro-A nd antiinflammatorycytokines, between Th1 and Th2 cytokines in depressedpatients: The effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry2009; 42: 182-188.
9. Voorhees JL, Tarr AJ, Wohleb ES, Godbout JP, Mo X, Sheridan JF, et al. Prolongedrestraint stress increases IL-6, reduces IL-10, causes persistent depressive-likebehavior that is reversed by recombinant IL-10. PLoS ONE 2013; 8: E58488.
10. Roque S, Correia-Neves M, Mesquita AR, Palha JA, Sousa N. Interleukin-10: A keycytokine in depression Cardiovasc Psychiatry Neurol 2009; 2009: 187894.
11. Pan Y, Lin W, Wang W, Qi X, Wang D, Tang M. The effects of central pro-and antiinflammatoryimmune challenges on depressive-like behavior induced by chronicforced swim stress in rats. Behav Brain Res 2013; 247: 232-240.
12. Mesquita AR, Correia-Neves M, Roque S, Castro AG, Vieira P, Pedrosa J, et al. IL-10modulates depressive-like behavior. J Psychiatr Res 2008; 43: 89-97.
13. Holtzman S, Abbey SE, Chan C, Bargman JM, Stewart DE. A genetic predispositionto produce low levels of IL-10 is related to depressive symptoms: A pilot study ofpatients with end stage renal disease. Psychosomatics 53: 155-161.
14. Williams ED, Steptoe A. The role of depression in the etiology of acute coronarysyndrome. Curr Psychiatry Rep 2007; 9: 486-492.
15. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovasculardisease: Epidemiology, biology, treatment. Arch Gen Psychiatry1998; 55: 580-592.
16. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognosticfactor in coronary heart disease: A meta-analysis of 6362 events among 146 538participants in 54 observational studies. Eur Heart J 2006; 27: 2763-2774.
17. Colbert LH, Visser M, Simonsick EM, Tracy RP, Newman AB, Kritchevsky SB, et al.Physical activity, exercise, inflammatory markers in older adults: Findings fromthe health, aging and body composition study. J Am Geriatr Soc 2004; 52:1098-1104.
18. Reuben DB, Judd-Hamilton L, Harris TB, Seeman TE. The associations betweenphysical activity and inflammatory markers in high-functioning older persons:macarthur studies of successful aging. J Am Geriatr Soc 2003; 51: 1125-1130.
19. Jerstad SJ, Boutelle KN, Ness KK, Stice E. Prospective reciprocal relations betweenphysical activity and depression in female adolescents. J Consult Clin Psychol 2010;78: 268-272.
20. Roshanaei-Moghaddam B, Katon WJ, Russo J. The longitudinal effects ofdepression on physical activity. Gen Hosp Psychiatry 2009; 31: 306-315.
21. Cooney GM, Dwan K, Greig CA, Lawlor DA, Rimer J, Waugh FR, et al. Exercise fordepression. Cochrane database Syst Rev 2013; 9: CD004366.
22. Schuch FB, Vancampfort D, Richards J, Rosenbaum S, Ward PB, Stubbs B. Exerciseas a treatment for depression: A meta-analysis adjusting for publication bias.J Psychiatr Res 2016; 77: 42-51.
23. Trivedi MH, Greer TL, Church TS, Carmody TJ, Grannemann BD, Galper DI, et al.Exercise as an Augmentation Treatment for Nonremitted Major Depressive Disorder.J Clin Psychiatry 2011; 72: 677-684.
24. Pedersen BK, Saltin B. Exercise as medicine-evidence for prescribing exercise astherapy in 26 different chronic diseases. Scand J Med Sci Sports 2015; 25: 1-72.
25. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: Focus on musclederivedinterleukin-6. Physiol Rev 2008; 88: 1379-1406.
26. Di Raimondo D, Tuttolomondo A, Buttà C, Casuccio A, Giarrusso L, Miceli G, et al.Metabolic and anti-inflammatory effects of a home-based programme of aerobicphysical exercise. Int J Clin Pract 2013; 67: 1247-1253.
27. Goldhammer E, Tanchilevitch A, Maor I, Beniamini Y, Rosenschein U, Sagiv M.Exercise training modulates cytokines activity in coronary heart disease patients.Int J Cardiol 2005; 100: 93-99.
28. Kayambu G, Boots R, Paratz J. Early physical rehabilitation in intensive carepatients with sepsis syndromes: A pilot randomised controlled trial. Intensive CareMed 2015; 41: 865-874.
29. Palmefors H, DuttaRoy S, Rundqvist B, Börjesson M. The effect of physical activityor exercise on key biomarkers in atherosclerosis-a systematic review. Atherosclerosis2014; 235: 150-161.
30. Smith JK, Dykes R, Douglas JE, Krishnaswamy G, Berk S. Long-term exercise andatherogenic activity of blood mononuclear cells in persons at risk of developingischemic heart disease. JAMA 1999; 281: 1722-1727.
31. Rethorst CD, Toups MS, Greer TL, Nakonezny Pa, Carmody TJ, Grannemann BDet al. Pro-inflammatory cytokines as predictors of antidepressant effects ofexercise in major depressive disorder. Mol Psychiatry 2012: 1-6.
32. Ekkekakis P. Honey, I shrunk the pooled SMD! Guide to critical appraisal of systematicreviews and meta-analyses using the Cochrane review on exercise fordepression as example. Ment Health Phys Act 2015; 8: 21-36.
33. Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. A metaanalysisof cognitive-behavioural therapy for adult depression, alone and incomparison with other treatments. Can J Psychiatry 2013; 58: 376-385.
34. Piette JD, Valenstein M, Himle J, Duffy S, Torres T, Vogel M, et al. Clinical complexityand the effectiveness of an intervention for depressed diabetes patients.Chronic Illn 2011; 7: 267-278.
35. Beissner K, Parker SJ, Henderson CR, Pal A, Iannone L, Reid MC. A cognitivebehavioralplus exercise intervention for older adults with chronic back pain: Race/ethnicity effect J Aging Phys Act 2012; 20: 246-265.
36. Gaudlitz K, Plag J, Dimeo F, Ströhle A. Aerobic exercise training facilitates theeffectiveness of cognitive behavioral therapy in panic disorder. Depress Anxiety2015; 32: 221-228.
37. Pentecost C, Farrand P, Greaves CJ, Taylor RS, Warren FC, Hillsdon M, et al.Combining behavioural activation with physical activity promotion for adultswith depression: Findings of a parallel-group pilot randomised controlled trial(BAcPAc). Trials 2015; 16: 367.
38. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress anddiscovery. Brain Behav Immun 2007; 21: 374-383.
39. Euteneuer F, Schwarz MJ, Schmidmaier R, Hennings A, Riemer S, Stapf TM, et al.Blunted exercise-induced mobilization of monocytes in somatization syndromesand major depression. J Affect Disord 2014; 166: 156-164.
40. Schlatter J, Ortunõ F, Cervera-Enguix S. Monocytic parameters in patients withdysthymia versus major depression. J Affect Disord 2004; 78: 243-247.
41. Kubera M, Kenis G, Bosmans E, Kajta M, Basta-Kaim A, Scharpe S, et al. Stimulatoryeffect of antidepressants on the production of IL-6. Int Immunopharmacol 2004; 4:185-192.
42. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H. Cytokine productionand serum proteins in depression. Scand J Immunol 1995; 41: 534-538.
43. Krause DL, Riedel M, Müller N, Weidinger E, Schwarz MJ, Myint A-M. Effects ofantidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines instimulated in vitro blood culture from depressed patients. Inflammopharmacology2012; 20: 169-176.
44. Lisi L, Camardese G, Treglia M, Tringali G, Carrozza C, Janiri L, et al. Monocytes fromdepressed patients display an altered pattern of response to endotoxin challenge.PLoS ONE 2013; 8: E52585.
45. Weizman R, Laor N, Podliszewski E, Notti I, Djaldetti M, Bessler H. Cytokine productionin major depressed patients before and after clomipramine treatment.Biol Psychiatry 1994; 35: 42-47.
46. Humphreys D, Schlesinger L, Lopez M, Araya AV. Interleukin-6 production andderegulation of the hypothalamic-pituitary-adrenal axis in patients with majordepressive disorders. Endocrine 2006; 30: 371-376.
47. Cyranowski JM, Marsland AL, Bromberger JT, Whiteside TL, Chang Y, MatthewsKA. Depressive symptoms and production of proinflammatory cytokines by peripheralblood mononuclear cells stimulated in vitro. Brain Behav Immun 2007; 21:229-237.
48. Guidi L, Bartoloni C, Frasca D, Antico L, Pili R, Cursi F, et al. Impairment oflymphocyte activities in depressed aged subjects. Mech Ageing Dev 1991; 60:13-24.
49. Miller GE, Rohleder N, Stetler C, Kirschbaum C. Clinical depression and regulationof the inflammatory response during acute stress. Psychosom Med 2005; 67:679-687.
50. Anisman H, Ravindran AV, Griffiths J, Merali Z. Endocrine and cytokine correlatesof major depression and dysthymia with typical or atypical features. Mol Psychiatry1999; 4: 182-188.
51. Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, et al.Inflammatory markers in major depression and melancholia. J Affect Disord 2001;63: 93-102.
52. Faul F, Erdfelder E, Lang A-G, Buchner A. G∗Power 3: A flexible statistical poweranalysis program for the social, behavioral, biomedical sciences. Behav ResMethods 2007; 39: 175-191.
53. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al.C-reactive protein and other circulating markers of inflammation in the predictionof coronary heart disease. N Engl J Med 2004; 350: 1387-1397.
54. American Psychiatric Association. Diagnostic and Statistical Manual ofMental Disorders: DSM-IV. American Psychiatric Association: Washington, DC, USA, 1994.
55. Wittchen H-U, Wunderlich U, Gruschitz S, Zaudig M. Strukturiertes KlinischesInterview für DSM-IV, Achse I (SKID-I). Hogrefe: Göttingen, 1997.
56. Hautzinger M. Kognitive Verhaltenstherapie bei Depressionen. Psychologie VerlagsUnion: Weinheim, 2003.
57. World Health Organization. Global Recommendations on Physical Activity forHealth. WHO Press: Geneva, Switzerland, 2010.
58. Craft LL, Perna FM. The benefits of exercise for the clinically depressed. Prim CareCompanion J Clin Psychiatry 2004; 6: 104-111.
59. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR, Montoye HJ, Sallis JF, et al. Compendiumof physical activities: Classification of energy costs of human physicalactivities. Med Sci Sports Exerc 1993; 25: 71-80.
60. Lutz R. The therapeutic concept of euthymic treatment. The little school ofpleasure. MMW Fortschr Med 2005; 147: 41-43.
61. Hautzinger M, Kühner C, Keller F. Das Beck Depressionsinventar II. Deutsche Bearbeitungund Handbuch zum BDI II. Harcourt Test Services: Frankfurt, 2006.
62. Craig CL, Marshall AL, SjÃ-StrÃ-M M, Bauman AE, Booth ML, Ainsworth BE, et al.International physical activity questionnaire: 12-country reliability and validity.Med Sci Sports Exerc 2003; 35: 1381-1395.
63. Grigoleit J, Kullmann JS, Wolf OT, Hammes F, Wegner A, Jablonowski S, et al. Dosedependenteffects of endotoxin on neurobehavioral functions in humans. PLoSONE 2011; 6: 1-10.
64. De Groote D, Zangerle P, Gevaert Y, Fassotte M, Beguin Y, Noizat-Pirenne F, et al.Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma andGM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine1992; 4: 239-248.
65. SAGE. Hierarchical Linear Models. Available at: Https://us.sagepub.com/en-us/nam/hierarchical-linear-models/book9230. Accessed on 12 March 2016.
66. Akaike H. A new look at the statistical model identification. IEEE Trans AutomatContr 1974; 19: 716-723.
67. Schwarz G. Estimating the dimension of a model. Ann Stat 1978; 6: 461-464.
68. Tabachnick B, Fidell F. Using Multivariate Statistics. Pearson: Boston, MA, USA, 2014.
69. Twisk J, de Boer M, de Vente W, Heymans M. Multiple imputation of missingvalues was not necessary before performing a longitudinal mixed-model analysis.J Clin Epidemiol 2013; 66: 1022-1028.
70. Peters SAE, Bots ML, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR, et al.Multiple imputation of missing repeated outcome measurements did not add tolinear mixed-effects models. J Clin Epidemiol 2012; 65: 686-695.
71. Bender R, Lange S. Adjusting for multiple testing-when and how J Clin Epidemiol2001; 54: 343-349.
72. Thomas E, Sokal Robert R, Jamesrohlf F. Introduction to Biostatistics, 2nd edn. W. H.Freeman and Co.: New York, NY, USA, 1987.
73. Pearson TA. Markers of inflammation and cardiovascular disease: Application toclinical and public health practice: A statement for healthcare professionals fromthe Centers for Disease Control and Prevention and the American Heart Association.Circulation 2003; 107: 499-511.
74. Ridker PM. Cardiology patient page. C-reactive protein: A simple test to helppredict risk of heart attack and stroke. Circulation 2003; 108: E81-e85.
75. Petersen AMW, Pedersen BK. The anti-inflammatory effect of exercise. J ApplPhysiol 2005; 98: 1154-1162.
76. Neefkes-Zonneveld CR, Bakkum AJ, Bishop NC, van Tulder MW, Janssen TW. Effectof long-term physical activity and acute exercise on markers of systemic inflammationin persons with chronic spinal cord injury: A systematic review. Arch PhysMed Rehabil 2015; 96: 30-42.
77. Ribeiro F, Alves AJ, Teixeira M, Miranda F, Azevedo C, Duarte JA, et al. Exercisetraining increases interleukin-10 after an acute myocardial infarction: A randomisedclinical trial. Int J Sports Med 2012; 33: 192-198.
78. Dimsdale JE, Moss J. Plasma catecholamines in stress and exercise. JAMA 1980;243: 340-342.
79. Hong S, Dimitrov S, Pruitt C, Shaikh F, Beg N. Benefit of physical fitness againstinflammation in obesity: Role of beta adrenergic receptors. Brain Behav Immun2014; 39: 113-120.
80. Hong S, Johnson TA, Farag NH, Guy HJ, Matthews SC, Ziegler MG, et al.Attenuation of T-lymphocyte demargination and adhesion molecule expressionin response to moderate exercise in physically fit individuals. J Appl Physiol 2004;98: 1057-1063.
81. Euteneuer F, Ziegler MG, Mills PJ, Rief W, Dimsdale JE. In Vivo-adrenergicreceptor responsiveness: Ethnic differences in the relationship with symptoms ofdepression and fatigue. Int J Behav Med 2013; 21: 843-850.
82. Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP. Modulatory effects of glucocorticoidsand catecholamines on human interleukin-12 and interleukin-10production: Clinical implications. Proc Assoc Am Physicians 1996; 108: 374-381.
83. Irwin MR, Olmstead R, Breen EC, Witarama T, Carrillo C, Sadeghi N, et al. Cognitivebehavioral therapy and tai chi reverse cellular and genomic markers of inflammationin late-life insomnia: A randomized controlled trial. Biol Psychiatry 2015; 78:721-729.
84. Riemann D. Insomnia and comorbid psychiatric disorders. Sleep Med 2007; 8: S15-S20.
85. Sivertsen B, Salo P, Mykletun A, Hysing M, Pallesen S, Krokstad S, et al. Thebidirectional association between depression and insomnia: The HUNT study.Psychosom Med 2012; 74: 758-765.
86. Kéri S, Szabó C, Kelemen O. Expression of Toll-like receptors in peripheral bloodmononuclear cells and response to cognitive-behavioral therapy in majordepressive disorder. Brain Behav Immun 2014; 40: 235-243.
87. Taylor CB, Conrad A, Wilhelm FH, Strachowski D, Khaylis A, Neri E, et al. Doesimproving mood in depressed patients alter factors that may affect cardiovasculardisease risk J Psychiatr Res 2009; 43: 1246-1252.
88. Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, et al.Randomized trial of behavioral activation, cognitive therapy, antidepressantmedication in the acute treatment of adults with major depression. J Consult ClinPsychol 2006; 74: 658-670.
89. Zhang D-F, Song X-T, Chen Y-D, Yuan F, Xu F, Zhang M, et al. Prognostic performanceof interleukin-10 in patients with chest pain and mild to moderate coronaryartery lesions-an 8-year follow-up study. J Geriatr Cardiol 2016; 13: 244-251.
90. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, et al.Serum level of the antiinflammatory cytokine interleukin-10 is an importantprognostic determinant in patients with acute coronary syndromes. Circulation2003; 107: 2109-2114.
91. Cavusoglu E, Marmur JD, Hojjati MR, Chopra V, Butala M, Subnani R, et al. Plasmainterleukin-10 levels and adverse outcomes in acute coronary syndrome. Am JMed 2011; 124: 724-730.
92. Han X, Boisvert WA. Interleukin-10 protects against atherosclerosis by modulatingmultiple atherogenic macrophage function. Thromb Haemost 2014; 113:505-512.
93. Parissis JT, Farmakis D, Nikolaou M, Birmpa D, Bistola V, Paraskevaidis I, et al.Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10levels predict adverse clinical outcome in chronic heart failure patients withdepressive symptoms: A 1-year follow-up study. Eur J Heart Fail 2009; 11: 967-972.
94. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, et al. The relationshipof depression and stressors to immunological assays: A metaanalyticreview. Brain Behav Immun 2001; 15: 199-226.
95. Herbert TB, Cohen S. Stress and immunity in humans: A meta-analytic review.Psychosom Med 1993; 55: 364-379.
96. Sjögren E, Leanderson P, Kristenson M, Ernerudh J. Interleukin-6 levels in relationto psychosocial factors: Studies on serum, saliva, in vitro production by bloodmononuclear cells. Brain Behav Immun 2006; 20: 270-278.
97. Brühmann BA, Schmidt ME, Steindorf K. Assessment of physical activity in epidemiologicalstudies: Are questionnaires obsolete in the era of accelerometryGMS Med Inform Biom Epidemiol 2014; 10; doi: 10.3205/mibe000155.
98. Wanner M, Probst-Hensch N, Kriemler S, Meier F, Autenrieth C, Martin BW.Validation of the long international physical activity questionnaire: Influence ofage and language region. Prev Med Rep 2016; 3: 250-256.